Topical Itraconazole for the Treatment of Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome or High-Frequency Basal Cell Carcinomas: A Phase 2, Open-Label, Placebo-Controlled Trial.

Sohn, Grace K; Kwon, Gina P; Bailey-Healy, Irene; Mirza, Amar; Sarin, Kavita; Oro, Anthony; Tang, Jean Y · JAMA Dermatol · 2019

rct · Level II

Where this comes from

Record sourced from PubMed, PMID 31339515.
Also identified by DOI 10.1001/jamadermatol.2019.1541 and PMC identifier 6659355.
No licence information is recorded for this record.
Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.

This phase 2, open-label, placebo-controlled examines topical itraconazole as a treatment for basal cell carcinoma.